FGF2 and diffuse large B-cell lymphoma: Previous studies have pointed out that serum bFGF detection in DLBCL patients can help clinicians better evaluate the patient's condition, clarify clinical analysis, predict prognosis, and then optimize and improve clinical diagnosis and treatment plans [4].